Pharmaceutical Product Development will provide research and development and vaccine services to the U.S. Army and the Biomedical Advanced Research and Development Authority as part of two new contracts.
The company said Thursday it will support Army R&D activities that work toward force readiness, improved health outcomes and the delivery of high-quality medical and preventative care to deployed service members under a potential 10-year contract.
PPD will also help the BARDA Medical Countermeasures Clinical Study Network test the U.S. avian influenza vaccine stockpile at the Centers for Disease Control and Prevention under a potential five-year contract.
Services covered under both contracts include medical product development, project management, strategic planning, market analysis, clinical development study support, pharmaceutical testing and nonclinical testing.
“PPD is pleased to contribute to the important missions of improving health outcomes for armed services personnel and helping protect the people of the United States against the threat of pandemic influenza,” said Bill Sharbaugh, chief operating officer of PPD.